Advancing Targeted Cancer Therapy with PARP Inhibitor Innovations "Executive Summary Poly (ADP-Ribose) Polymerase (PARP) Inhibitors Market Trends: Share, Size, and Future Forecast
The global Poly (ADP-Ribose) Polymerase (PARP) inhibitors market size was valued at USD 10.00 billion in 2024 and is expected to reach USD 23.89 billion by 2032, at a CAGR of 11.50% during the forecast period
Keeping into consideration the customer requirement, Poly...
0 Shares
34 Views
0 Reviews
Chinese